The adverse effects of<unk>  appear similar to those of other VEGF inhibitors. In the CONFIRM trials, the most common side effects were high blood pressure, gastrointestinal upset (diarrhea, nausea, and vomiting), fatigue, and dizziness.
Vatalanib
Pegaptanib
Nintedanib
Tivozanib
Abrocitinib
Pazopanib
Alectinib
Gilteritinib